Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2018 / N 3

Современный взгляд на фармакотерапию кашля
А.А. Зайцев

References
1. Morice AH, McGarvey L, Pavord I; British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax 2006;61:1-24.
2. Zaytsev AA, Okovitiy SV, Kryukov EV. Cough. Physicians’ manual. Moscow: Burdenko NN Main Military Clinical Hospital; 2015. 59 p. (In Russian).
3. Asthma Workgroup, Chinese Society, Respiratory, Diseases (CSRD), Chinese Medical Association. The Chinese national guidelines on diagnosis and management of cough (December 2010). Chinese Medical Journal 2011 Oct;124(20):3207-19.
4. Zaytsev AA, Okovitiy SV. Cough: rational pharmacotherapy and differential diagnosis. Therapeutic Archive 2014;86(12):85-91 (In Russian).
5. Finley C, Chan DS, Garrison S, Korownyk C, Kolber MR, Campbell S, Eurich DT, Lindblad AJ, Vandermeer B, Allan GM. What are the most common conditions in primary care? Systematic review. Canadian Family Physician 2018 Nov;64(11):832-40.
6. Morice A. Epidemiology of cough. Pulmonary Pharmacology and Therapeutics 2002;15(3):253-9.
7. Zaytsev AA, Sinopalnikov AI. Rational pharmacotherapy for acute respiratory viral infections. Consilium Medicum 2008;10(10):80-6 (In Russian).
8. Zaytsev AA. Pharmacotherapy and prevention of acute respiratory viral infections. Russian Medical Journal 2009;17(23):1525-9 (In Russian).
9. Chuchalin AG, Ambrosimov VN. Cough. Moscow: Echo; 2012. 128 p. (In Russian).
10. Koskela HO, Lätti AM, Pekkanen J. The impacts of cough: a cross-sectional study in a Finnish adult employee population. ERJ Open Research 2018 Oct;4(4):00113-2018.
11. Chuchalin AG, Khaltaev N, Antonov NS, Galkin DV, Manakov LG, Antonini P, Murphy M, Solodovnikov AG, Bousquet J, Pereira MH, Demko IV. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. International Journal of Chronic Obstructive Pulmonary Disease 2014 Sep;9:963-74.
12. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019. Available from: http://www.goldcopd.org Accessed 2019 Jan 17.
13. Sinopalnikov AI, Zaytsev AA. Pharmacotherapy of chronic obstructive pulmonary disease exacerbations: modern aspects. Lechashchiy Vrach 2009;10:45-9 (In Russian).
14. Koo HK, Park SW, Park JW, Choi HS, Kim TH, Yoon HK, Yoo KH, Jung KS, Kim DK. Chronic cough as a novel phenotype of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 2018 May;13:1793-801.
15. Gibson P, Chang A, Glasgow N. CICADA: Cough In Children and Adults: Diagnosis and Assessment. Australian cough guidelines summary statement. The Medical Journal of Australia 2010 Mar;192(5):265-71.
16. Sinopalnikov AI, Zaytsev AA. Slowly resolving/unresolving community-acquired pneumonia. Russian Medical Journal 2009;17(5):361-7 (In Russian).
17. Zaytsev AA, Moiseyev SV. Non-cystic fibrosis bronchiectasis: epidemiology, diagnosis and treatment. Clinical Pharmacology and Therapy 2017;26(5):19-24 (In Russian).
18. Irwin R, Curley FJ, French CL. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. The American Review of Respiratory Disease 1990 Mar;141(3):640-7.
19. Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Respiratory Research 2016 Aug;3(1):e000137.
20. Dicpinigaitis PV, Morice AH, Birring SS, McGarvey L, Smith JA, Canning BJ, Page CP. Antitussive drugs – past, present, and future. Pharmacological Reviews 2014 Mar;66(2):468-512.
21. Zaytsev AA. Mucoactive cough therapy: what is beyond the horizon? Lechashchiy Vrach 2018;10:22-7 (In Russian).
22. Okovitiy SV, Anisimova NA. Pharmacological approaches to antitussive therapy. Russian Medical Journal 2011;19(23):1450-7 (In Russian).
23. Dal Negro R, Wedzicha J, Iversen M, Fontana G, Page C, Cicero AF, Pozzi E, Calverley PMA; RESTORE group; RESTORE study. Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study. The European Respiratory Journal 2017 Oct;50(4). pii: 1700711.
24. Hamilton WFD, Palmer KNV, Gent M. Expectorant action of bromhexine in chronic obstructive bronchitis. BMJ 1970 Aug;3(5717):260-1.
25. Beeh KM, Beier J, Esperester A, Paul LD. Antiinflammatory properties of ambroxol. European Journal of Medical Research 2008 Dec;13(12):557-62.
26. Prevention of chronic bronchitis exacerbations with ambroxol (mucosolvan retard). An open, long-term, multicenter study in 5,635 patients. Respiration 1989;55(Suppl 1):84-96.
27. Matthys H, de MC, Carls C, Ryś A, Geib A, Wittig T. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneimittelforschung 2000 Aug;50(8):700-11.
28. Malerba M, Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opinion on Drug Metabolizm & Toxicology 2008 Aug;4(8):1119-29.
29. Baldini G, Gucci M, Tarò D, Memmini C. A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children. Minerva Pediatrica 1989 Feb;41(2):91-5.
30. Berni M, Collina A, Zavarrini G. Ambroxol in pediatric broncho-pulmonary pathology. Clinica Terapeutica (Roma) 1983;106(5):351-5.
31. Kamei J, Nakanishi Y, Ishikawa Y, Hayashi SS, Asato M, Ohsawa M. Possible involvement of tetrodotoxin-resistant sodium channels in cough reflex. European Journal of Pharmacology 2011 Feb;652(1-3):117-20.
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]